Back to search

Article

Identification and External Validation of a Prognostic Signature Based on Myeloid-Derived Suppressor Cell-Related lncRNAs for Hepatocellular Carcinoma

2026-02-03

Abstract excerpt

<title>Abstract</title> <p>Background Myeloid-derived suppressor cells (MDSCs) exhibit notable immunosuppressive and pro-tumorigenic properties. However, the relationship between long noncoding RNAs (lncRNAs) and hepatocellular carcinoma (HCC) remains insufficiently explored. Our research established a forecast system relying on lncRNAs linked to MDSCs for evaluating HCC patient survival. Methods Data from HCC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb95580e-bb71-5612-b950-02376b5cb4f7
DOI
10.21203/rs.3.rs-8563745/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification and External Validation of a Prognostic Signature Based on Myeloid-Derived Suppressor Cell-Related lncRNAs for Hepatocellular CarcinomaDOI 10.21203/rs.3.rs-8563745/v1
Development of a Myeloid-Derived Suppressor Cells-Related Genes Predictive Signature for Prognostic Survival and Immunotherapeutic Responses in Hepatocellular CarcinomaSemantic proximity
Construction of a Prognostic m6A-related lncRNA Signature to Predict Immunotherapy and Chemotherapy Response in Hepatocellular CarcinomaSemantic proximity
Integrative study reveals the prognostic and immunotherapeutic value of CTCs/CTMs -related prognostic signature in Hepatocellular carcinomaSemantic proximity
Development of N6-methyladenosine Related Signature as New Biomarker for Prognosis of Hepatocellular Carcinoma and Correlates with Sorafenib and anti-PD-1 Immunotherapy Treatment ResponseSemantic proximity
Establishment of a prognostic signature for hepatocellular carcinoma using disulfidptosis-related lncRNAsSemantic proximity
A Novel Immune-Metabolic Prognostic Model Stratifies Survival and Personalizes Therapy in Hepatocellular CarcinomaSemantic proximity
Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature for Hepatocellular CarcinomaSemantic proximity
Identification of a Candidate Risk Model Based on Cancer- Associated Fibroblasts-Related Gene Signature Predicting the Prognosis in Hepatocellular CarcinomaSemantic proximity
Machine Learning-Based Disulfidptosis-Related lncRNA Signature Predicts Prognosis, Immune Infiltration and Drug Sensitivity in Hepatocellular CarcinomaSemantic proximity
Identification of Biomarkers of Hepatocellular Carcinoma&nbsp;Gene Prognosis Based on Immune-Related lncRNA Signature of Transcriptome DataSemantic proximity
Development and validation of a robust immune-related risk signature for hepatocellular carcinomaSemantic proximity
An Anoikis-related Gene Signature for Forecasting Prognosis, Tumor Microenvironment, and Treatment Response in Hepatocellular CarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.